Dr. Martens shareholder exercises over-allotment option
Dr. Martens said that the broker Goldman Sachs International exercised the over-allotment option granted by IngreLux, a Luxembourg company owned by funds advised by the British investment firm Permira, as part of the initial public offering of the British footwear company. With the exercise of the option, an additional 52,500,005 ...
SIGN-IN if you are already a subscriber of Shoe Intelligence.
Subscribe today
Your membership benefits:
- Unlimited access to shoeintelligence.com - all insight, analysis and statistics 24h/day available online
- Our executive edition of Shoe Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Unlimited access to shoeintelligence.com - all insight, analysis and statistics 24h/day available online
- Powerful search and access to over 16,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Organisation-wide access across offices, people and devices
To continue reading this article REGISTER NOW.